Erin Ross is a director on the Science Philanthropy Accelerator for Research and Collaboration (SPARC) team at the Milken Institute. She applies her expertise in health systems, analyzing scientific evidence's role in health policy implementation and identifying ways the scientific and policy communities can collaborate.
Managing Director, SPARC, Milken Institute Philanthropy
Cara Altimus, PhD is a managing director on the Science Philanthropy Accelerator for Research and Collaboration (SPARC) team at the Milken Institute, leading the science and health innovation portfolio. A PhD neuroscientist, Altimus advises individual philanthropists and foundations on the state of research for various areas including neurodegenerative disease and mental health, identifying opportunities where their capital can make the biggest impact.
Type 1 diabetes, or T1D, once commonly known as juvenile diabetes, is an autoimmune disease in which the immune system attacks the insulin-producing cells of the pancreas. The disease affects people of all ages and causes numerous negative and lifelong health consequences. Currently, there is no means of preventing or curing T1D, but screening for T1D autoantibodies, especially in the pediatric years, can play an important role in diagnosing the disease early.
Implementing preventive care, especially in pediatrics, can be a challenge. In this report, generously funded by The Leona M. and Harry B. Helmsley Charitable Trust, the Milken Institute Center for Strategic Philanthropy has laid out an actionable framework, complete with strategies and milestones, for implementing screening for T1D autoantibodies in the general population.
This roadmap was developed with substantial input from a variety of stakeholder groups across the T1D research, clinical, and nonprofit community, as well as decision makers in preventive health policy. There are four goals and two supporting goals with a total of 16 action items that will aid the entire T1D community as it works toward the objective of general population autoantibody screening.
The 26th annual Milken Institute Global Conference convened the best minds in the world to tackle its most urgent challenges and realize its most exciting opportunities. Throughout the four-day event, our health teams curated nearly three...
Even before the onset of the COVID-19 pandemic, the United States was confronted with a number of significant policy concerns. Today, working together to solve those challenges is more imperative than ever. The Milken Institute is committed...
The Milken Institute Center for Strategic Philanthropy and the Ann Theodore Foundation have released a new request for proposals (RFP) focused on understanding the underlying biology of sarcoidosis. Applications are open through January 20...
Countries undergoing population aging today are facing a much different experience than their historical counterparts. One only needs to look at the countries in Asia to see how these trends are unfolding. Demographic aging is happening...
In this collection of essays from the Center for the Future of Aging, experts identify challenges and opportunities in realizing the potential of healthy, productive and purposeful aging.
Technical Update Dementia presents a pernicious gender-based health disparity in the United States, inflicting a disproportionate burden on women as both patients and caregivers. Given the rapid increase in the population of older Americans...
Nationwide protests in the summer of 2020 sparked many of the largest US corporations to pledge more than $200 billion to advance racial equity and confront the nation’s history of systemic racism. Nonprofits, government agencies, and...
The Ann Theodore Foundation Breakthrough Sarcoidosis Initiative (ATF-BSI) is now accepting applications for two-year research projects that seek to increase our foundational understanding of sarcoidosis through projects focused on the...
The Financial Innovations Labs® and FasterCures teams have collaborated on a project to identify new models for financing the antimicrobial resistant antibiotic pipeline. These past 18 months have demonstrated how consequential public...